Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhengshi Lin
Immunogenicity and Cross-Reactivity of 2009–2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly
PLoS ONE
Multidisciplinary
Related publications
Clinical Reactivity and Immunogenicity of Hemagglutinin Influenza Vaccine
Archives of Virology
Medicine
Virology
Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
An Analysis of National Target Groups for Monovalent 2009 Pandemic Influenza Vaccine and Trivalent Seasonal Influenza Vaccines in 2009-10 and 2010-11
BMC Infectious Diseases
Infectious Diseases
Cross-Reactive Antibody to Swine Influenza A(H3N2) Subtype Virus in Children and Adults Before and After Immunisation With 2010/11 Trivalent Inactivated Influenza Vaccine in Canada, August to November 2010
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine
Pediatric Research
Child Health
Pediatrics
Perinatology
Immunogenicity and Safety of an Egg-Based Inactivated Quadrivalent Influenza Vaccine (GC3110A) Versus Two Inactivated Trivalent Influenza Vaccines With Alternate B Strains: A Phase Ⅲ Randomized Clinical Trial in Adults
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Safety, Efficacy, and Immunogenicity of Flublok in the Prevention of Seasonal Influenza in Adults
Therapeutic Advances in Vaccines
Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults Aged 18–60 Years
Epidemiology and Vaccine Prevention
